{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:28:07Z","timestamp":1783783687821,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eprac.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T10:31:46Z","timestamp":1696415506000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7404-890X","authenticated-orcid":false,"given":"Aayushi","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Hosseinpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshit","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekant","family":"Avula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawahar","family":"Durrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eprac.2023.09.012_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrendo.2013.122","article-title":"Testosterone and insulin resistance in the metabolic syndrome and T2DM in men","volume":"9","author":"Rao","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib2","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/JOE-12-0582","article-title":"Testosterone: a vascular hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.eprac.2023.09.012_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.steroids.2014.05.010","article-title":"Adverse health effects of testosterone deficiency (TD) in men","volume":"88","author":"Traish","year":"2014","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib4","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-12-0455","article-title":"Testosterone: a metabolic hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.eprac.2023.09.012_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.metabol.2018.03.007","article-title":"Testosterone replacement therapy: for whom, when and how?","volume":"86","author":"Tsametis","year":"2018","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.eprac.2023.09.012_bib6","first-page":"664","article-title":"Testosterone replacement therapy and cardiovascular events","volume":"45","author":"\u00c7atako\u011flu","year":"2017","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib7","doi-asserted-by":"crossref","first-page":"R566","DOI":"10.1152\/ajpregu.00174.2016","article-title":"Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined?","volume":"311","author":"Traish","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10.1016\/j.eprac.2023.09.012_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjp.0705141","article-title":"The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?","volume":"138","author":"Jones","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.eprac.2023.09.012_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9149(99)00630-X","article-title":"Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease","volume":"85","author":"Ong","year":"2000","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.eprac.2023.09.012_bib10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/hrt.39.11.1217","article-title":"Effect of testosterone cypionate on postexercise ST segment depression","volume":"39","author":"Jaffe","year":"1977","journal-title":"Br Heart J"},{"issue":"2","key":"10.1016\/j.eprac.2023.09.012_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jc.2003-031492","article-title":"Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men","volume":"89","author":"Woodhouse","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2023.09.012_bib12","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/1060028014539918","article-title":"Risk of myocardial infarction in older men receiving testosterone therapy","volume":"48","author":"Baillargeon","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.eprac.2023.09.012_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eprac.2023.09.012_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2023.09.012_bib15","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone levels","volume":"97","author":"Shores","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib16","first-page":"759","article-title":"Re: testosterone products: drug safety communication - FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke","volume":"194","author":"Seftel","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"17","key":"10.1016\/j.eprac.2023.09.012_bib17","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/01.CIR.0000125854.51637.06","article-title":"Endogenous sex hormones and progression of carotid atherosclerosis in elderly men","volume":"109","author":"Muller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2023.09.012_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.eprac.2023.09.012_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.eprac.2023.09.012_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2023.09.012_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF03350341","article-title":"Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome","volume":"33","author":"Aversa","year":"2010","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib22","doi-asserted-by":"crossref","first-page":"e1096","DOI":"10.1210\/clinem\/dgaa917","article-title":"Testosterone replacement therapy added to intensive lifestyle intervention in older men with obesity and hypogonadism","volume":"106","author":"Barnouin","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2023.09.012_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2023.09.012_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2015.8881","article-title":"Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial","volume":"314","author":"Basaria","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2023.09.012_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/13685538.2012.699562","volume":"15","author":"Behre","year":"2012","journal-title":"Aging Male"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib26","first-page":"699","article-title":"Effect of testosterone solution 2% on testosterone concentration, sex drive and energy in hypogonadal men: results of a placebo controlled study","volume":"195","author":"Brock","year":"2016","journal-title":"J\u00a0Urol"},{"issue":"16","key":"10.1016\/j.eprac.2023.09.012_bib27","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.CIR.102.16.1906","article-title":"Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study","volume":"102","author":"English","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.eprac.2023.09.012_bib28","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/dc13-2845","article-title":"Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial","volume":"37","author":"Gianatti","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2023.09.012_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2023.09.012_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","article-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study","volume":"73","author":"Kalinchenko","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2023.09.012_bib31","first-page":"1149","article-title":"One-year efficacy and safety study of a 1.62% testosterone gel in hypogonadal men: results of a 182-day open-label extension of a 6-month double-blind study","volume":"9","author":"Kaufman","year":"2012","journal-title":"J\u00a0Sex Med"},{"issue":"6","key":"10.1016\/j.eprac.2023.09.012_bib32","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1532-5415.2010.02865.x","article-title":"Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty","volume":"58","author":"Kenny","year":"2010","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/andr.13147","article-title":"Muscle function following testosterone replacement in men on opioid therapy for chronic non-cancer pain: a randomized controlled trial","volume":"10","author":"Kolind","year":"2022","journal-title":"Andrology"},{"issue":"5","key":"10.1016\/j.eprac.2023.09.012_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1530\/EJE-08-0634","article-title":"Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study","volume":"160","author":"Legros","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2023.09.012_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2023.09.012_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehi443","article-title":"Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial","volume":"27","author":"Malkin","year":"2006","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.eprac.2023.09.012_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/1074248418784020","article-title":"Testosterone replacement therapy in deficient patients with chronic heart failure: a randomized double-blind controlled pilot study","volume":"23","author":"Navarro-Pe\u00f1alver","year":"2018","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.eprac.2023.09.012_bib38","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jcem.82.6.3988","article-title":"Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial","volume":"82","author":"Sih","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2023.09.012_bib39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","article-title":"Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial","volume":"65","author":"Sinclair","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.eprac.2023.09.012_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9343(01)00813-0","article-title":"Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age","volume":"111","author":"Snyder","year":"2001","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.eprac.2023.09.012_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jc.2009-1251","article-title":"Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Srinivas-Shankar","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2023.09.012_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.rmed.2004.02.015","article-title":"Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial","volume":"98","author":"Svartberg","year":"2004","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.eprac.2023.09.012_bib43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.eprac.2023.09.012_bib44","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/bju.12037","article-title":"Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study","volume":"111","author":"Tan","year":"2013","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.eprac.2023.09.012_bib45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.1840060502","article-title":"Testosterone treatment of men with alcoholic cirrhosis: a double-blind study","volume":"6","year":"1986","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.eprac.2023.09.012_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2023.09.012_bib47","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.eprac.2023.09.012_bib49","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/14740338.2014.950653","article-title":"Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis","volume":"13","author":"Corona","year":"2014","journal-title":"Expet Opin Drug Saf"},{"issue":"17","key":"10.1016\/j.eprac.2023.09.012_bib50","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eprac.2023.09.012_bib51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1210\/jc.2013-3570","article-title":"Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011","volume":"99","author":"Layton","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2023.09.012_bib52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23005724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23005724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T22:27:45Z","timestamp":1732746465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23005724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1530891X23005724"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.09.012","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}